Jihao Zhou

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid et al. · European Urology · 2013 · 401 citations

Urological Research, Urology, Voiding Dysfunction +5

Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial

Roger R. Dmochowski, Christopher R. Chapple, Victor W. Νitti et al. · The Journal of Urology · 2010 · 397 citations

Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo‐controlled dose‐finding study in idiopathic overactive bladder

Eric Rovner, Michael Kennelly, Heinrich Schulte‐Baukloh et al. · Neurourology and Urodynamics · 2011 · 172 citations

Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway

Yonghui Li, Li Gao, Xufeng Luo et al. · Blood · 2012 · 169 citations · Full text

Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects

Carlo L. Bello, Laurie Sherman, Jihao Zhou et al. · Anti-Cancer Drugs · 2006 · 134 citations

Nutrition, Oral Bioavailability, Healthy Subjects +17